Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-027339

Chair and CEO sold 27,887 shares at an average $67.66 ($1,886,957)

  • Chair and CEO acquired 6,830 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-20 Sale : show line 1 in the form 10b5-1 −9,489 $66.87 $634,529 325,798 D
2025-05-20 Sale : show line 2 in the form 10b5-1 −4,480 $67.96 $304,461 321,318 D
2025-05-20 Sale : show line 3 in the form 10b5-1 −7,088 $68.49 $485,457 314,230 D
2025-05-20 Exercise or conversion : show line 4 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-05-20 Sale : show line 5 in the form 10b5-1 −2,863 $66.90 $191,535 237,891 I
2025-05-20 Sale : show line 6 in the form 10b5-1 −2,251 $68.13 $153,361 235,640 I
2025-05-20 Sale : show line 7 in the form 10b5-1 −1,716 $68.54 $117,615 233,924 I
Open-market sales · 27,887 sh · avg $67.66 · $1,886,957

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-20 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −6,830 163,990 I
Loading xslF345X05/wk-form4_1747948703.xml…